MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
5.09
-0.20 (-3.69%)
Feb 26, 2026, 3:00 PM EST - Market open
MiMedx Group Stock Forecast
Stock Price Forecast
The 5 analysts that cover MiMedx Group stock have a consensus rating of "Strong Buy" and an average price target of $10, which forecasts a 96.66% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $12.
Price Target: $10 (+96.66%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MiMedx Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 1 | 1 |
| Buy | 1 | 1 | 1 | 2 | 2 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Initiates $10 | Buy | Initiates | $10 | +96.66% | Feb 23, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $12 → $8 | Buy | Maintains | $12 → $8 | +57.33% | Feb 17, 2026 |
| Lake Street | Lake Street | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +96.66% | Jan 20, 2026 |
| Mizuho | Mizuho | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +96.66% | Dec 17, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $11 → $12 | Buy | Maintains | $11 → $12 | +135.99% | Jul 31, 2025 |
Financial Forecast
Revenue This Year
415.63M
from 348.88M
Increased by 19.13%
Revenue Next Year
404.08M
from 415.63M
Decreased by -2.78%
EPS This Year
0.34
from 0.28
Increased by 19.01%
EPS Next Year
0.11
from 0.34
Decreased by -66.67%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 432.2M | 488.2M | ||||
| Avg | 415.6M | 404.1M | ||||
| Low | 392.0M | 345.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 23.9% | 17.4% | ||||
| Avg | 19.1% | -2.8% | ||||
| Low | 12.4% | -16.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.42 | 0.17 | |
| Avg | 0.34 | 0.11 | |
| Low | 0.27 | 0.05 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 48.5% | -50.1% | |
| Avg | 19.0% | -66.7% | |
| Low | -3.0% | -85.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.